Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France
A Pariente, R Lassalle, C Dureau-Pournin… - European journal of …, 2014 - Springer
Purpose The recommended pharmacotherapy for secondary prevention of acute coronary
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta …
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta …
Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France.
J Bezin, A Pariente, R Lassalle… - European Journal of …, 2013 - europepmc.org
Purpose The recommended pharmacotherapy for secondary prevention of acute coronary
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta …
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta …
Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France
J Bezin, A Pariente, R Lassalle… - … Journal of Clinical …, 2014 - search.proquest.com
The recommended pharmacotherapy for secondary prevention of acute coronary syndrome
(ACS) is long-term treatment with a combination of four therapeutic classes: beta-blockers …
(ACS) is long-term treatment with a combination of four therapeutic classes: beta-blockers …
[PDF][PDF] Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France
J Bezin, A Pariente, R Lassalle, C Dureau-Pournin… - 2013 - researchgate.net
Purpose The recommended pharmacotherapy for secondary prevention of acute coronary
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes …
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes …
Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France.
J Bezin, A Pariente, R Lassalle… - … Journal of Clinical …, 2014 - search.ebscohost.com
Purpose: The recommended pharmacotherapy for secondary prevention of acute coronary
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta …
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta …
Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France
J Bezin, A Pariente, R Lassalle… - European Journal of …, 2014 - infona.pl
Purpose The recommended pharmacotherapy for secondary prevention of acute coronary
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta …
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta …
Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France
J Bezin, A Pariente, R Lassalle… - … journal of clinical …, 2014 - pubmed.ncbi.nlm.nih.gov
Purpose The recommended pharmacotherapy for secondary prevention of acute coronary
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta …
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta …
[引用][C] Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France
J BEZIN, A PARIENTE, R LASSALLE… - European journal of …, 2014 - pascal-francis.inist.fr
Use of the recommended drug combination for secondary prevention after a first occurrence
of acute coronary syndrome in France CNRS Inist Pascal-Francis CNRS Pascal and Francis …
of acute coronary syndrome in France CNRS Inist Pascal-Francis CNRS Pascal and Francis …